Serum antibodies to HTLV-I in Thai patients with chronic progressive myelopathy, multiple sclerosis, myopathy and in HIV-seropositive intravenous drug abusers. NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Serum antibodies to HTLV-I in Thai patients with chronic progressive myelopathy, multiple sclerosis, myopathy and in HIV-seropositive intravenous drug abusers.

Asian Pac J Allergy Immunol. 1989 Jun;7(1):33-5. Unique Identifier : AIDSLINE MED/89322476
Hemachudha T; Phanuphak P; Sirivichayakul S; Phanthumchinda K; Department of Medicine, Chulalongkorn University Hospital,; Bankok, Thailand.

Abstract: Antibodies to HTLV-I were assayed in sera of 9 patients with progressive myelopathy, 11 with multiple sclerosis, 5 with myopathy and in 10 HIV-seropositive intravenous heroin abusers. Clinical features in 9 cases with progressive myelopathy were not different from those previously described in tropical spastic paraparesis associated with HTLV-I infection. No detectable HTLV-1 antibody was found in the sera of any of the 35 patients studied.
Keywords: Adult Aged Child Chronic Disease Female Human HIV Seropositivity/*IMMUNOLOGY HTLV-I Antibodies/*ANALYSIS Injections, Intravenous Male Middle Age Multiple Sclerosis/*IMMUNOLOGY Muscular Atrophy, Spinal/*IMMUNOLOGY Substance Abuse/*IMMUNOLOGY Support, Non-U.S. Gov't Thailand JOURNAL ARTICLE

KWDadultagedchildchronicdiseasefemalehumanhivseropositivity/KWDimmunologyhtlv-iantibodies/KWDanalysisinjections,intravenousmalemiddleagemultiplesclerosis/KWDimmunologymuscularatrophy,spinal/KWDimmunologysubstanceabuse/KWDimmunologysupport,non-uKWDsKWDgov'tthailandjournalarticle
891130
M89B0543

Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .